東誠藥業(002675.SZ):子公司東誠北方通過藥品GMP現場符合性檢查
格隆匯12月7日丨東誠藥業(002675.SZ)公佈,近日,公司全資子公司煙台東誠北方製藥有限公司(簡稱“東誠北方”)收到山東省藥品監督管理局簽發的《藥品GMP符合性檢查結果通知書》(編號:GMP2022134)。
檢查範圍:小容量注射劑;生產地址:山東省煙台市經濟技術開發區天津北路22號(注射劑二車間小容量注射劑生產線);檢查結論:經藥品GMP符合性檢查,基本符合《藥品生產質量管理規範》(2010年版)的要求。
東誠北方該次通過藥品GMP現場符合性檢查,表明東誠北方相關劑型生產線符合GMP要求。相關劑型產品可投入生產,有利於完善公司產品結構,提升生產能力,擴大產品市場管線,對公司未來穩健發展有着積極的推動作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.